Signal Detection of Adverse Events Associated with PCSK9 Inhibitors: A Nationwide Sequence Symmetry and Combined Worldwide Disproportionality Analysis.

Viguier T, Bezin J, Hlavaty A, Khouri C, Pariente A

Open source

DOI
10.1007/s40264-026-01731-0
Published
2026 Sep 22
Container
Drug safety
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40264-026-01731-0,
  title = {Signal Detection of Adverse Events Associated with PCSK9 Inhibitors: A Nationwide Sequence Symmetry and Combined Worldwide Disproportionality Analysis.},
  author = {Viguier T and Bezin J and Hlavaty A and Khouri C and Pariente A},
  year = {2026},
  journal = {Drug safety},
  doi = {10.1007/s40264-026-01731-0},
  url = {https://doi.org/10.1007/s40264-026-01731-0}
}

RIS

TY  - JOUR
TI  - Signal Detection of Adverse Events Associated with PCSK9 Inhibitors: A Nationwide Sequence Symmetry and Combined Worldwide Disproportionality Analysis.
AU  - Viguier T
AU  - Bezin J
AU  - Hlavaty A
AU  - Khouri C
AU  - Pariente A
PY  - 2026
JO  - Drug safety
DO  - 10.1007/s40264-026-01731-0
UR  - https://doi.org/10.1007/s40264-026-01731-0
ER  - 

APA

T, V., J, B., A, H., C, K., & A, P. (2026). Signal Detection of Adverse Events Associated with PCSK9 Inhibitors: A Nationwide Sequence Symmetry and Combined Worldwide Disproportionality Analysis.. Drug safety. https://doi.org/10.1007/s40264-026-01731-0

Source records